Overview

Vevo Therapeutics uses advanced AI models and its Mosaic platform to enhance drug discovery by generating high-resolution in vivo data, which studies drug interactions within living organisms. This method allows them to identify new drug targets and candidates that traditional approaches may miss. They serve pharmaceutical companies and research institutions by providing insights into drug efficacy and gene expression at a single-cell level, making the drug discovery process faster and more cost-effective. The company's goal is to uncover better drugs for a wider range of patients, addressing critical needs in the pharmaceutical industry.

Simplify's Take

What believers are saying

• Partnership with Parse Biosciences boosts AI-powered drug discovery capabilities.
• $12M seed funding supports scaling operations and enhancing the Mosaic platform.
• Growing demand for single-cell RNA profiling increases pharmaceutical interest in Vevo's services.

What critics are saying

• AI models risk obsolescence without continuous innovation and updates.
• Increased competition from new AI-driven drug discovery startups threatens market share.
• Data privacy concerns could lead to stricter regulations affecting operations.

What makes Vevo Therapeutics unique

• Vevo's Mosaic platform offers high-resolution in vivo data for drug discovery.
• Their AI models analyze drug interactions within living organisms, not isolated cells.
• Vevo's single-cell RNA profiling reveals drug actions across diverse patient populations.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$12M

Above

Industry Average

Funded Over

1 Rounds

Notable Investors:

General Catalyst

Notable Investors:

General Catalyst

$12,000,000

Seed

Dec 2022

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.

Seed Funding Comparison

Above Average

Industry standards

Ind Avg. $3.3M

$500k

$1.5M

$2M

$2.3M

$3M

$12M